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Abstract
 
Systemic fungal infections with primary and opportunistic pathogens have become increasingly
common and represent a growing health menace in patients with AIDS and other immune de-
ficiencies. T lymphocyte immunity, in particular the CD4
 
 
 
 Th 1 cells, is considered the main
defense against these pathogens, and their absence is associated with increased susceptibility. It
would seem illogical then to propose vaccinating these vulnerable patients against fungal infec-
tions. We report here that CD4
 
 
 
 T cells are dispensable for vaccine-induced resistance against
experimental fungal pulmonary infections with two agents, 
 
Blastomyces dermatitidis
 
 an extracellu-
lar pathogen, and 
 
Histoplasma capsulatum
 
 a facultative intracellular pathogen. In the absence of T
helper cells, exogenous fungal antigens activated memory CD8
 
 
 
 cells in a major histocompati-
bility complex class I–restricted manner and CD8
 
 
 
 T cell–derived cytokines tumor necrosis
factor 
 
 
 
, interferon 
 
 
 
, and granulocyte/macrophage colony-stimulating factor–mediated dura-
ble vaccine immunity. CD8
 
 
 
 T cells could also rely on alternate mechanisms for robust vaccine
immunity, in the absence of some of these factors. Our results demonstrate an unexpected plas-
ticity of immunity in compromised hosts at both the cellular and molecular level and point to
the feasibility of developing vaccines against invasive fungal infections in patients with severe
immune deficiencies, including those with few or no CD4
 
 
 
 T cells.
Key words: immunity • T cells • CD4 help • fungi • AIDS
 
Introduction
 
Opportunistic fungal infections have become increasingly
common, especially in AIDS patients. Infections with
 
Cryptococcus neoformans
 
, 
 
Histoplasma capsulatum
 
, 
 
Pneumocystis
carinii
 
, 
 
Coccidioides immitis
 
, 
 
Candida albicans
 
, and 
 
Blastomyces
dermatitidis
 
 are collectively a major cause of morbidity and
mortality in this patient population (1, 2). Treatment of
these infections with amphotericin-B must be given for an
extended duration, causes frequent and toxic side effects,
and generally has to be followed by life-long suppressive
therapy with antifungal azoles (2). No vaccines are available
against fungi.
Cellular immunity mediated by T lymphocytes, and in
particular CD4
 
 
 
 Th 1 cells, is considered the main defense
against pathogenic fungi (3). The fact that AIDS patients
with decreased CD4 T cells are predisposed to opportunis-
tic fungal infections supports this premise (4). Furthermore,
without CD4
 
 
 
 T cells, patients with disseminated crypto-
coccosis, even with the best available anti-fungal therapy,
cannot clear the fungus and sterilize their tissues (5, 6).
CD4
 
 
 
 T cells would appear to be crucial both for acquisi-
tion of protective immunity and combat against established
opportunistic fungal infections.
CD8
 
 
 
 T cells play a pivotal role in immune responses
against many viruses and tumors, and may also contribute
to immunity to fungi (7–12). There are multiple paths for
activating native CD8
 
 
 
 T cells. Most models have pointed
to and clarified the requirement of CD4
 
 
 
 T helper cells for
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CD4
 
 
 
 T Cells Are Dispensable for Antifungal Vaccine Immunity
 
activation of naive CD8
 
 
 
 T cells. However, antiviral CTL
have been induced with little or no requirement for CD4
 
 
 
T helper cells (13–15), and CD8
 
 
 
 T cells have been shown
to provide self-help in inducing antiviral peptide responses
when the cells were present at a sufficiently high precursor
frequency (16).
Herein, we tested, in immune-suppressed mice lacking
CD4
 
 
 
 T cells, whether we could induce vaccine resistance
against experimental infection with two of the principal
systemic fungi 
 
B. dermatitidis
 
 and 
 
H. capsulatum
 
, which
cause disease in both immune-competent and immune-
deficient hosts, with the latter being more susceptible. We
report that CD4
 
 
 
 T cells are dispensable for induction of
vaccine immunity against both fungal pathogens. CD8
 
 
 
 T
cells compensate in the absence of CD4
 
 
 
 cells. Hence,
CD8
 
 
 
 T cells alone, without CD4
 
 
 
 T cell help, can medi-
ate efficient antifungal vaccine immunity. Vaccine resis-
tance by CD8
 
 
 
 T cells was restricted by MHC class I and
mediated by the production of TNF-
 
 
 
, and to a lesser ex-
tent, IFN-
 
 
 
 and GM-CSF. Although regulatory cytokines
TNF-
 
 
 
 and IFN-
 
 
 
 contributed significantly to the expres-
sion of CD8
 
 
 
 T cell immunity in wild-type mice, each of
them also was shown to be dispensable for vaccine immu-
nity in TNF-
 
 
 
 
 
/
 
 
 
 and IFN-
 
 
 
 
 
/
 
 
 
 mice.
Our results underscore the plasticity of immune re-
sponses in the immune-compromised, CD4
 
 
 
 T cell–defi-
cient host. Our findings demonstrate that residual elements
of a compromised immune system can be recruited effec-
tively against opportunistic and invasive fungal infections.
Our study has general implications for immunologists and
others trying to develop vaccine strategies for people with
compromised immunity, including AIDS.
 
Materials and Methods
 
Fungi.
 
Strains used were American Type Culture Collection
26199 (17), the isogenic, attenuated mutant lacking BAD1, desig-
nated strain #55 (18), and 
 
H. capsulatum
 
 strain G217B. Isolates of
 
B. dermatitidis
 
 were maintained as yeast on Middlebrook 7H10 agar
with oleic acid-albumin complex (Sigma-Aldrich) at 37
 
 
 
C; 
 
H. cap-
sulatum
 
 was maintained at 37
 
 
 
C on Brain Heart Infusion Agar.
 
Mouse Strains.
 
Inbred strains of mice including C57BL/6, the
T lymphocyte specific Thy 1.1 allele carrying congenic C57BL/6
strain B6.PL-
 
Thy1
 
a
 
/Cy (stock #000406; reference 19), CD4-defi-
cient C57BL/6-
 
Cd4
 
tm1Mak
 
 (stock #002663; reference 20), 
 
 
 
-2-
microglobulin–deficient B6.129P2-
 
 
 
2
 
M
 
tm1Unc
 
 (stock #002087; ref-
erence 21), transporter associated with antigen processing (TAP)1-
deficient B6.129S2-
 
Abc2
 
tm1Arp
 
 (stock #002944; reference 22),
IFN-
 
 
 
–deficient C57BL/6-
 
Ifng
 
tm1Ts
 
 (stock #002287; references
23–25), and TNF-
 
 
 
–deficient B6.129-
 
Tnf
 
tm1Gkl
 
 (stock # 003008;
reference 26) and control B6129SF2 (stock #101045) were ob-
tained from The Jackson Laboratory and MHC class II–deficient
C57BL/6Tac-Abb
 
tm1
 
 (27) and C57BL/6 wild-type control mice
were purchased from Taconic. Male mice 6–7 wk of age at the
time of purchase were housed and cared for throughout these ex-
periments according to guidelines of the University of Wisconsin
Animal Care Committee, who approved all aspects of this work.
 
In Vivo Cell Depletion and Neutralization of IFN-
 
 
 
, TNF-
 
 
 
, and
GM-CSF.
 
CD4
 
 
 
 and CD8
 
 
 
 T cells were depleted by mAb
treatment. mAb GK1.5 (rat IgG2b anti-CD4) was purchased
 
from American Type Culture Collection. mAb 2.43 (rat IgG2b
anti-CD8) was provided by Dr. A. Rakhmilevich, UW-Madi-
son, Madison, WI; mAb XMG1.2 (rat IgG1 anti–IFN-
 
 
 
) was
provided by R. Seder, National Institutes of Health, Bethesda,
MD; and mAbs XT22.1 and MP1–22E9 (rat IgG2a anti-TNF-
 
 
 
and rat IgG2a anti-GM-CSF, respectively) were provided by
Dr. G. Deepe, University of Cincinnati, Cincinnati, OH with
permission of Dr. J. Abrams, DNAX Research Institute, Palo
Alto, CA. Ascites was made in BALB/c Nu/Nu males. Rat IgG
in ascites was ammonium-sulfate precipitated and quantified by
measuring OD
 
280
 
. For depletion, mice received 250 
 
 
 
g anti-
CD4 mAb or anti-CD8 mAb intravenously a day before infec-
tion and weekly afterward. Cell depletion analyzed by FACS
 
®
 
showed 
 
 
 
95% depletion of desired subsets in the peripheral
blood and lung (data not depicted). For neutralization of IFN-
 
 
 
,
TNF-
 
 
 
, and GM-CSF, mice were injected intravenously with 1
mg, 0.5 mg, and 0.5 mg mAb, respectively, 4 to 6 h before in-
fection, and then intraperitoneally every other day (IFN-
 
 
 
) or
every 3 d (TNF-
 
 
 
 and GM-CSF) afterward with mAb doses
above. Controls were given 500 
 
 
 
g of rat IgG (Sigma-Aldrich)
by a similar schedule.
 
Real Time RT-PCR.
 
Lung cells were obtained by crushing
the organs (
 
n
 
 
 
 
 
 6–8 mice/group) in 40 
 
 
 
M cell strainers (Becton
Dickinson) to obtain single-cell suspensions. Erythrocytes were
lysed with NH
 
4
 
Cl-Tris solution and washed twice. Total RNA
was isolated from 1–5 
 
 
 
 10
 
6
 
 lung cells using the RNeasy Mini
Kit (QIAGEN). RNA was purified over RNeasy mini columns
and treated with the RNase-free DNase Set (QIAGEN). 0.5 to 1
 
 
 
g RNA in a final volume of 20 
 
 
 
l was reverse transcribed using
random hexamers and the TaqMan RT-PCR Kit (Applied Bio-
systems). 5 
 
 
 
l of a 1:10 dilution of cDNA was amplified in a final
volume of 25 
 
 
 
l PCR reaction using SYBR Green Supermix
(Bio-Rad Laboratories). The following primers were used at a fi-
nal concentration of 100 nM: IFN-
 
 
 
 (forward CCTGCGGC-
CTAGCTCTGA; reverse CAGCCAGAAACAGCCATGAG),
TNF-
 
 
 
 (forward TGGCCTCCCTCTCATCAGTT; reverse TCC-
TCCACTTGGTGGTTTGC), GM-CSF (forward GGGCGC-
CTTGAACATGAC; reverse TTGTGTTTCACAGTCCGTT-
TCC), and 18S rRNA as an endogenous control gene (forward
CGCCGCTAGAGGTGAAATTCT; reverse CGAACCTCCG-
ACTTTCGTTCT). Amplification was performed in an iCycler
iQ™ real-time PCR detection system (Bio-Rad Laboratories)
and assayed under the same conditions for all targets: 5 min at
95
 
 
 
C, 45 cycles of 15 s at 95
 
 
 
C, and 45 s at 60
 
 
 
C. Transcript
quantity was calculated using the comparative C
 
T
 
 method (28)
and reported as n-fold difference relative to a calibrator cDNA
(i.e., sample from unvaccinated mice). Data represent an average
of two independent experiments.
 
Intracellular Cytokine Staining.
 
Lung cells were obtained as
described above. An aliquot of isolated cells was stained for sur-
face CD4 and CD8 using anti-CD4 and anti-CD8 CyChrome
mAbs (clone H129.19 and clone 53–6.7; BD Biosciences) to de-
termine the percentage of CD4
 
 
 
 and CD8
 
 
 
 T cells. The num-
bers of CD4
 
 
 
 and CD8
 
 
 
 T cells per lung were derived by mul-
tiplying the percentage of cells by the total number of lung cells
isolated. The rest of the cells were stimulated for 4 h with anti-
CD3 (clone 145–2C11; 0.1 
 
 
 
g/ml) and anti-CD28 (clone
37.51; 1 
 
 
 
g/ml) in the presence of 2 
 
 
 
M monensin (Sigma-
Aldrich) to halt egress of cytokines from the cells. After cells
were washed and fixed in 2% paraformaldehyde at 4 C over-
night, they were permeabilized with 0.1% saponin in PBS con-
taining 0.1% bovine serum albumin and 0.1% sodium azide. Per-
meabilized cells were stained with phycoerythrin-conjugatedT
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
1407 Wüthrich et al.
mAbs and isotype controls (BD Biosciences) for IFN-  (clone
XMG1.2), TNF-  (clone MP6-XT22), and GM-CSF (clone
MP1–22E9) in 20% mouse serum for 30 min at 4 C, washed,
and analyzed by FACS®. Lung cells were harvested serially dur-
ing infection and stained intracellularly for cytokines. Lympho-
cytes were gated on CD4 and CD8 and cytokine expression
within each gate analyzed. The number of cytokine producing
CD4  and CD8  T cells per lung was calculated by generating
the product of percent cytokine producing cells and the number
of CD4  and CD8  cells in the lung. Density of cytokine pro-
ducing T cells in the lung was calculated by dividing the total
number of type 1 cytokine producing T cells by the total num-
ber of lung hematopoietic cells.
Vaccination and Experimental Infection with B. dermatitidis.
Mice were vaccinated as described (29) twice, 2 wk apart, each
time receiving a subcutaneous injection of 105 #55 yeast at each
of two sites, dorsally and at the base of the tail, unless otherwise
stated. To generate immune CD8  T cells for adoptive transfer,
mice were depleted of CD4  T cells with mAb during vaccina-
tion to evoke CD8  T cell immunity. These mice were immu-
nized subcutaneously with strain #55 yeast as above, but three
times, 2 wk apart. 2 wk after the final vaccination, mice received
200  g of soluble yeast cytosol extract (YCE)* (29) or soluble
hen egg lysozyme (HEL) as a control antigen emulsified in com-
plete Freund’s adjuvant. 12 d later, draining lymph node cells and
splenocytes were harvested and CD8  T cells purified using
 CD8-coated immuno-magnetic beads (Miltenyi Biotec). CD8 
T cells isolated from Thy 1.1  mice were transferred intrave-
nously into irradiated [5.5 gray (Gy)] Thy1.2    2M /  and
 2M /  mice, whereas CD8  T cells from Thy 1.2  mice were
transferred into nonirradiated Thy 1.2  recipients. Irradiated
mice were rested for 8 wk before infection, nonirradiated mice
were challenged the day after transfer. Transferred Thy 1.1 
CD8  T cells were monitored by FACS® analysis in the spleen,
lymph nodes, and the lung of recipient mice during the period of
recovery and infection.
Mice were infected intratracheally with 2   102 to 2   103
wild-type strain 26199 yeast as described (29). Infected mice were
monitored for survival or analyzed 2 wk after infection for extent
of lung infection, determined by plating of homogenized lung
and enumeration of yeast CFU on Brain Heart Infusion (BHI;
Difco) agar.
Vaccination, Depletion of T Cells, and Challenge with H. capsula-
tum. Mice were immunized twice, 2 wk apart, each time re-
ceiving a subcutaneous injection of 2   106 H. capsulatum yeasts,
strain G217B, that were suspended in 0.1 ml of HBSS, at the base
of the tail. 2 wk after the second immunization, mice were chal-
lenged intranasally with 1.25   107 yeasts. For depletion of
CD4  cells, mice were administered 100  g of mAb to CD4
(clone GK 1.5) intraperitoneally beginning on days  7,  3, and
on the day of immunization and weekly thereafter. One group of
CD4-depleted mice also received 100  g of mAb to CD8 (clone
2.43) intraperitoneally beginning 1 d before challenge with 1.25  
106 yeasts and on the day of challenge. Administration of mAb to
CD8 was continued weekly (30). Controls received an equal
amount of rat IgG. Lungs and spleens were removed and homog-
enized in HBSS, and 100  l of homogenate was dispensed onto
plates containing brain heart infusion agar supplemented with 5%
defibrinated sheep erythrocytes, 1% glucose, and 0.01% cysteine
hydrochloride (wt/vol). Plates were incubated at 30 C for 7 d,
and colony forming units enumerated (9).
Histology. Lung tissue was fixed in 10% formalin and embed-
ded in paraffin wax. Sections 5- m thick were stained with he-
matoxylin and eosin and Gomori’s methenamine silver. Areas of
pneumonic consolidation were measured at a final projected
magnification of 8.8 and expressed as a percentage of total lung
areas in sections. The number of yeast was counted in 20 fields
with a 60  objective, projected on a TV screen, and expressed as
yeast/high power field.
Statistical Analysis. Kaplan Meier survival curves were gener-
ated (31). Survival times of infected mice alive by the end of the
study were regarded as censored. Time data were analyzed by the
log rank statistic (Mantel-Haenszel test; reference 32) and exact P
values were computed using the statistical packaged Stat Xact-3
by CYTEL Software Corporation. The number of TNF- , IFN- ,
and GM-CSF producing CD4  and CD8  T cells and differences
in number of CFU were analyzed using the Wilcoxon Rank test
for nonparametric data (31). A P value of   0.05 is considered
statistically significant.
Results
CD4  T Cells Are Dispensable during Induction of Vaccine
Immunity. Depletion of T cell subsets during the period
of vaccination (defined as the induction phase of vaccine
immunity) and throughout the period after infection (de-
fined as the expression phase of vaccine immunity) gave
unanticipated results. Mice depleted of either CD4  or
CD8  T cells acquired levels of vaccine immunity similar
to that of rat IgG-treated controls, as assessed by lung CFU
analysis (Fig. 1 A). Animals depleted of both CD4  and
CD8  T cells were as susceptible as unvaccinated controls.
Thus, T cells are required for vaccine immunity, but CD4 
T cells appear to be dispensable when absent during induc-
tion of vaccine immunity. CD8  T cells are essential in a
CD4  T cell–deficient host.
Survival analysis of CD4-depleted wild-type animals sup-
ported the above findings and indicated that lung CFU data
are a reliable predictor of survival (33). Mice depleted of
CD4  T cells during induction and expression of vaccine
immunity survived significantly longer than unvaccinated
mice (mean, 123   11 d vs. 23   2 d; P   0.0001). At 75 d
after infection, all unvaccinated mice were dead, whereas
80% of CD4  T cell–depleted mice were still alive. Ulti-
mately, 35% of CD4-depleted mice survived a lethal chal-
lenge with virulent, wild-type yeast over a prolonged pe-
riod of 200 d after infection; all of the survivors had no
detectable CFU in their lungs (detection limit   5 CFU),
indicating that they had acquired sterilizing immunity. In
comparison, 100% of vaccinated, non-T cell–depleted mice
survived the lethal challenge and cleared the infection.
Thus, in the absence of CD4  T cells, vaccination greatly
prolonged survival and a significant proportion of those ani-
mals survived and acquired sterilizing immunity.
Vaccine immunity evoked in the absence of CD4  T
cells was durable and persisted for at least 8 wk after vacci-
nation. CD4-depleted mice that were rested for 8 wk af-
ter vaccination (but maintained CD4 deficient) remained
*Abbreviations used in this paper:  2M, beta-2-microglobulin; DC, dendritic
cell; HEL, hen egg lysozyme; ODN, oligodeoxynucleotides; YCE, yeast
cytosol extract.T
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highly resistant to lethal infection. 6 out of 10 CD4-
depleted mice acquired sterilizing immunity and the re-
maining four mice had 20–200 lung CFU 25 d after infec-
tion. In contrast, unvaccinated mice appeared moribund with
a lung burden of 5.2   2.9   106 CFU at this time point. All
vaccinated wild-type mice had cleared the infection. Thus,
resting of vaccinated CD4-depleted mice indicated durable
immunity and even greater resistance to infection.
CD4 /  Mice Acquire Robust Vaccine Immunity. Be-
cause depletion of CD4 T cells might not be complete, and
residual cells could provide sufficient help for other effector
cells, we investigated vaccine immunity in CD4 /  mice.
Remarkably, all vaccinated CD4  T cell-knockout mice
survived an extended period after infection (Fig. 1 B); 9
out of 11 had in fact acquired sterilizing immunity, and the
other two had low numbers of CFU in their lungs (200 and
280 CFU). Survival data generated with class II-knockout
mice were similar to those reported for CD4-depleted
wild-type mice. Thus, the results obtained using mice con-
genitally deficient in CD4  cells support the data using
CD4  T cell depletion and the notion that CD4  T cells
are dispensable.
We examined the histological appearance of inflamma-
tion in the lungs of infected mice. Unvaccinated CD4
knockout mice and wild-type mice each had 50% of their
lungs replaced with granulomas, which contained 20.7
yeast/mm2 of tissue. By contrast, vaccinated, CD4 knock-
out mice and wild-type mice had only 7 and 0.8% of their
lung tissue inflamed with granulomas, which contained 1.9
and 3.6 yeast/mm2, respectively (Table I). The architecture
and cellular composition of the granulomas in vaccinated
mice was unaffected by absence of CD4  T cells (data not
depicted). Hence, the extent and microscopic appearance
of granulomatous inflammation in the lung was dependent
on the resistance phenotype, rather than on the cellular
subset mediating resistance.
CD4  T Cells Are Dispensable in Vaccine immunity to H.
capsulatum. We determined whether our findings could
be extended to other pathogenic and opportunistic fungi,
and tested this in an experimental model of pulmonary
histoplasmosis, a fungal disease that causes frequent and
life-threatening opportunistic infection in AIDS patients.
All the mice that had been vaccinated in either the pres-
ence or absence of CD4  T cells survived a lethal pulmo-
Figure 1. Role of CD4  and CD8  T cells during induction of vac-
cine immunity. (A) Lung CFU analysis. Vaccinated mice (10–12/group)
were depleted of T cell subsets during vaccination and infection. Mice
were infected with 2   103 yeast and analyzed for lung CFU 14–16 d af-
ter infection. Panel A shows an average of two independent experiments.
*, P   0.1983 vs. vaccinated control (rat IgG treated), **, P   0.9825, vs.
control, ***, P   0.7 vs. unvaccinated mice. (B) Survival of vaccinated,
CD4  T cell knockout mice and wild-type mice (10–11/group). Vacci-
nated CD4-KO/CD8- mice were depleted of CD8  T cells after vacci-
nation and throughout infection. *, P   0.0001 vs. unvaccinated mice;
**, P   0.0077 vs. vaccinated CD4-KO mice. (C) CD8  T cells mediate
vaccine immunity to H. capsulatum. Anti-CD4-/anti-CD8 denotes vacci-
nated CD4-depleted mice that were depleted of CD8  T cells after vacci-
nation and throughout infection. Eight mice/group were studied. *, P  
0.0002 vs. unvaccinated mice or anti-CD4-/anti-CD8 mAb treated mice.
Table I. Histological Analysis of B. dermatitidis Infection and 
Granulomatous Inflammation
Group Treatment
Granuloma/
areaa
No. yeastb/
mm2
Exp. 1
CD4 knockout Unvaccinated 49% 20.7
Wild-type Unvaccinated 51% 20.7
CD4 knockout Vaccinated 7% 1.9
Wild-type Vaccinated 0.8% 3.6
Exp. 2
Wild-type Unvaccinated 50% 21.5
Wild-type Vaccinated 0% 0
cWild-type/CD4  Vaccinated 4% 0.3
dWild-type/CD4 /CD8  Vaccinated 32% 9.1
aPercentage of microscopic field inflamed with granulomas.
bNumber of yeast per square millimeter of lung tissue section viewed
under 400  magnification.
cC57BL/6 mice (4/group) were depleted of CD4  T cells during the
induction and expression phase of vaccine immunity.
dIn addition to CD4  T cell depletion as described abovec, CD8  T
cells were depleted during vaccine expression.T
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nary challenge with the wild-type virulent strain, and ac-
quired sterilizing immunity by 50 d after infection
(detection limit of 200 CFU; Fig. 1 C). In contrast, unvac-
cinated mice and CD4  T cell–depleted mice that were
depleted of CD8  T cells after infection died within 10–
20 d after infection. Thus, vaccine resistance also can be
raised against pulmonary histoplasmosis in the absence of
CD4  T cells.
CD8  T Cells Are Required during the Efferent Phase of
Vaccine Immunity. Studies above (Fig. 1 A) showed that
CD8  T cells must be present during vaccine induction
when CD4  T cells are absent, but did not address whether
CD8  T cells are required and responsible for immunity
during the expression or efferent phase. To determine if
CD8  T cells serve as effectors during the efferent phase,
we used two approaches. First, mice in whom CD4  T
cells were depleted during induction and expression of vac-
cine immunity were depleted of CD8  T cells upon infec-
tion and afterward. Elimination of CD8  T cells after
infection reduced resistance 150-fold, compared with con-
trols depleted only of CD4  T cells (Fig. 2 A). Similarly,
elimination of CD8  T cells after infection reduced the
mean survival time from 200   0 d to 49   5 d (P  
0.007) in vaccinated CD4 knockout mice (Fig. 1 B) and
from 123   11 d to 49   5 d (P   0.0001) in vaccinated
CD4-depleted wild-type mice. The corresponding survival
rates in these two respective groups went from 100 to 40%
at 200 d after infection, and from 80 to 0% at 75 d after in-
fection. Vaccine induced resistance against pulmonary his-
toplasmosis in CD4-depleted mice depended exclusively
on CD8  T cells. Elimination of CD8  cells in those mice
reduced the survival rate from 100 to 0%.
In a second approach, we adoptively transferred immune
CD8  T cells that had been generated in wild-type mice in
the absence of CD4  T cells. Blastomyces immune CD8  T
cells lowered lung CFU 10- to 15-fold compared with
mice that got HEL-CD8  T cells or no T cells, respec-
tively (Fig. 2 B, Exp. 1). Resistance was adoptively trans-
ferred by Blastomyces-immune CD8  T cells in a dose-
dependent manner, using cell numbers from 106 to 2   107
(Fig. 2 B, Exp. 2).
Taken together, our findings indicate that, when CD4 
T cells are absent, CD8  T cells are required during the in-
duction phase and participate as effectors during the effer-
ent phase of vaccine immunity against B. dermatitidis and H.
capsulatum infection.
Antigen Presentation to CD8 Cells Requires Class I Mole-
cules. To investigate how CD8  T cells exert vaccine-
induced resistance against B. dermatitidis, a predominantly
extracellular pathogen, we considered the following two
possibilities. Protective CD8  T cells either recognized
fungal antigen on the yeast’s surface directly and in the ab-
sence of MHC restriction, as previously hypothesized for
other fungi (34), or alternatively, they became activated by
cross-presentation of exogenous antigens displayed on MHC
class I molecules.
To determine whether MHC class I is necessary for
CD8  T cell vaccine immunity, we adoptively transferred
CD8  T cells from vaccinated CD4  T cell depleted, wild-
type mice into naive class I–deficient mice. Immune CD8 
T cells reduced the lung CFU by a factor of 440 in  2M-
sufficient mice, but had no effect on lung CFU after trans-
fer into  2M-deficient mice (Fig. 3 A). We replicated these
findings in  2M /  and  2M /  mice that had been sub-
lethally irradiated before transfer and infected eight weeks
later to avoid the possibility that transferred CD8  cells
from   2M-sufficient mice could have been rejected in
 2M-deficient mice (35). In this scheme, adoptively trans-
ferred, immune CD8  T cells were found to persist and
expand in  2M /  and  2M /  mice during the period of
recovery and infection (data not depicted); they reduced
lung CFU in  2M /  mice by 165-fold, but again had no
effect in  2M /  mice. Thus, MHC class I molecules are
required and likely cross-present exogenous fungal antigens
to vaccine induced CD8  T cells.
Molecular Mechanisms of CD8  T Cell Vaccine Immunity.
Effector mechanisms of CD8  T cells include, but are not
limited to, the production of type 1 regulatory cytokines.
By real-time PCR of lung cells 48 h after infection, cyto-
Figure 2. CD8  T cells mediate resistance in the absence of CD4  T
cells. (A) Depletion of CD8  T cells impairs resistance. C57BL/6 mice
were depleted of CD4  T cells during vaccination (induction). As indi-
cated in histogram bars, after infection, mice also were depleted of CD4 
cells alone or together with CD8  T cells. Controls were vaccinated mice
treated with rat-IgG (C) or unvaccinated mice. Mice were infected with
2   103 yeast and analyzed for lung CFU 14 d later. *, P   0.0001 vs.
CD4-depleted mice. Data represent an average of two independent ex-
periments (n   10 mice/group). (B) CD8  T cells transfer resistance. In
experiment 1, naive mice (8/group) received either Blastomyces immune
(YCE) CD8  T cells, no cells, or control HEL-CD8  T cells. Mice were
infected 1d later with 103 yeast, and lung CFU analyzed 2 wk after infec-
tion, *, P   0.001 vs. mice receiving either HEL-CD8  T cells or no
cells. Data show one representative experiment of three independent ex-
periments. In experiment 2, naive mice (8–9/group) received various
numbers of YCE-CD8  T cells or no cells and were infected with 2  
102 yeast. 2 wk after infection, lung CFU was analyzed. *, P   0.004 vs.
mice receiving either 106 YCE-CD8  T cells or no cells.T
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kine transcript was elevated in vaccinated (CD4 depleted
and wild-type) mice compared with unvaccinated mice;
TNF-  transcript was 3–4-fold higher, IFN- , 24–29-fold
higher, and GM-CSF 10–24 fold higher (P   001). There-
fore, we investigated whether CD8  T cells mediate their
effects via production of TNF- , GM-CSF, or IFN-  (Fig.
3 B). Mice were depleted of CD4  T cells during vaccina-
tion and throughout infection to evoke CD8  T cell im-
munity. After infection, the mice were neutralized alone or
in combination for TNF- , IFN- , and GM-CSF or given
rat IgG as a control. Neutralization of GM-CSF, IFN- ,
and TNF-  independently, or IFN-  and TNF-  to-
gether, sharply reduced resistance, compared with treat-
ment with rat IgG. Neutralization of IFN-  and TNF- 
together yielded lung CFU values comparable to those in
unvaccinated control mice. Hence, these two type 1 cyto-
kines appear to be the most critical in mediating CD8  T
cell immunity to B. dermatitidis infection.
Rapid Influx of Cytokine Producing CD8  T Cells
Into Lung Coincides with CFU Reduction. To determine
whether CD8  (and CD4 ) cells produce TNF- , IFN- ,
and GM-CSF, we monitored the expression of these cyto-
kines by intracellular staining of lung T cells ex vivo. The
number of lung CD4  and CD8  cells combined that pro-
duced TNF- , IFN- , and GM-CSF rose sharply between
2 and 4 d after infection in vaccinated wild-type mice and
vaccinated CD4-depleted mice versus unvaccinated mice
(Fig. 4 A). In vaccinated wild-type mice, cytokine produc-
ing T cells were largely CD4  cells, whereas CD8  cells
contributed to a lesser extent as assessed by the frequency
(Fig. 4 B) and number of cytokine-producing T cells (Ta-
Figure 3. Essential role of MHC class I and type 1 cytokine production
in protective CD8  T cells. (A) Adoptive transfer of CD8  T cells into
 2M-deficient mice. 1.8   107 CD8  T cells isolated from spleen and
lymph node of CD4-depleted wild-type mice were transferred into
 2M /  and  2M /  recipients. Mice were infected with 4   102 yeast
the next day, and analyzed for lung CFU 20 d later. Data show one repre-
sentative experiment of two independent experiments (n   10 mice/
group). *, P   0.0003 vs. untransferred  2M /  mice; **, P   0.112 vs.
untransferred  2M /  mice. (B) Neutralization of TNF- , GM-CSF, and
IFN- . C57BL/6 mice were depleted of CD4  T cells during induction
and expression of vaccine immunity. mAbs against TNF-  and IFN- 
alone or together, GM-CSF, CD8  T cells, or rat IgG control (C) as in-
dicated in histogram bars were administered after and throughout infec-
tion. Mice were infected with 2   103 yeast, and lung CFU was analyzed
14 d later. Data represent an average of three independent experiments
(n   10 mice/group). *, P   0.008 vs. all groups. Figure 4. (continues on facing page)T
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ble II). Although not statistically significant, the number of
cytokine producing CD8  cells showed a tendency to be
increased in vaccinated CD4-depleted mice, as compared
with vaccinated wild-type mice. Most importantly, in both
vaccinated groups of mice, the number of cytokine pro-
ducing T cells peaked at 4 d after infection, whereas in un-
vaccinated mice, comparable numbers of cytokine produc-
ing T cells did not appear until 8–12 d after infection. The
peak influx of cytokine producing T cells in vaccinated
mice coincided with a significant reduction in lung CFU in
those mice compared with unvaccinated mice (Fig. 4 C).
At day 4, the number of lung CFU in vaccinated mice was
already 15-fold lower than in unvaccinated mice, perhaps a
critical reduction in burden of lung infection that set the
stage for the final outcome. By day 26, unvaccinated mice
appeared moribund and harbored 3   106 yeast in their
Figure 4. Intracellular produc-
tion of TNF- , IFN- , and
GM-CSF by lung T cells coin-
cides with reduction in lung
CFU. (A) Total number of type-1
cytokine producing lung T cells
after  B. dermatitidis infection in
vaccinated and unvaccinated
mice (n   pool of 6–12/group at
each time point). TNF- , IFN- ,
and GM-CSF producing cells are
combined for CD4  and CD8 
T cells at each time point, which
represent an average of four in-
dependent experiments. *, P  
0.004, and **, P   0.03 vs. un-
vaccinated mice for all three cy-
tokines. (B) Type 1-cytokine re-
sponse by CD4  and CD8  T
cells at day 2 and 4 after infec-
tion. Analyses are gated on
CD4  and CD8  T cells; num-
bers represent the percentage of
CD4  and CD8  T cells positive
for IFN- , TNF- , and GM-
CSF. Data show a representative
experiment (n    pool of 6–8
mice/group at each time point)
of four independent experi-
ments. (C) Kinetics of lung CFU
clearance. Mice were infected
with 102 yeast and analyzed for
lung CFU serially after infection
(detection limit   5 CFU).
Number with sterilizing immu-
nity (undetectable CFU) is de-
picted as a fraction of those tested
(n   4 mice/group). *, P   0.03
vs. vaccinated mice and vacci-
nated, CD4-depleted mice. Sim-
ilar results were found when the
experiment was repeated with a
higher inoculum (103 yeast). (D)
Density of cytokine producing T
cells in lung (n   pool of 6–12
mice/group at each time point).
Total number of type 1-cytokine
expressing T cells (CD4  and
CD8  cells combined) ex-
pressed as a fraction of total lung
hematopoietic cells. *, P   0.03
vs. unvaccinated mice for all
three cytokines. **, P   0.08 vs.
unvaccinated mice for TNF- 
and GM-CSF.T
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lungs, whereas both groups of vaccinated mice had largely
cleared the infection.
To explore why unvaccinated mice failed to resist infec-
tion even though they eventually produced comparable
numbers of cytokine expressing lung T cells by day 8 to 12,
we analyzed the density of cytokine producing effector
cells in the lung (Fig. 4 D). Vaccinated wild-type mice and
vaccinated, CD4-depleted mice reached their highest den-
sities of effector cells as early as day 4 and maintained them
over the period investigated. Despite the significant in-
crease in number of cytokine producing cells after day 8
postinfection, unvaccinated mice never reached the same
levels of effector cell density. This was largely a conse-
quence of the increasing number of hematopoietic cells
migrating into the lungs (from one million at day 0 up to
20 million cells at day 12), presumably the result of increas-
ing CFU over time in unvaccinated mice. In contrast, in
both vaccinated groups of mice, total lung hematopoietic
cells increased rapidly to three million cells and remained at
that level over the period investigated. Lung CFU fell re-
ciprocally in proportion to the high density of lung effector
cells (data not depicted). Thus, vaccine-induced, protective
CD8  cells likely mediate their effect(s) via production of
TNF- , IFN- , and GM-CSF.
CD8  T Cells Show Plasticity in Cytokine Repertoire for
Vaccine Immunity. To ascertain the absolute requirements
for IFN-  and TNF-  in CD8  T cell vaccine immunity,
we vaccinated transgenic mice deficient in these cytokines
in the absence of CD4  T cells. Remarkably, in both trans-
genic mouse strains, CD8  T cells compensated for the ab-
sence of either cytokine (Fig. 5 A). We analyzed the com-
pensatory mechanisms. In CD4-depleted IFN-  /  mice,
neutralization of TNF-  or GM-CSF, or depletion of
CD8  T cells, during vaccine expression increased lung
CFU 980-fold, 206-fold, and 1385-fold, respectively, com-
pared with the rat IgG control (Fig. 5 A). Hence, TNF- ,
and to a lesser extent GM-CSF, regulate expression of
CD8  T cell immunity in the absence of IFN- . By con-
trast, in vaccinated, CD4-depleted TNF-  /  mice, neu-
tralization of GM-CSF, but not IFN- , after infection
Table II. Number ( 103) of Type 1 Cytokine-producing CD4  and CD8  T Cells in Lung after B. dermatitidis Infection as Measured by 
Intracellular Cytokine Staining
IFN-  TNF-  GM-CSF
Day CD4  CD8  CD4  CD8  CD4  CD8 
Unvaccinated
05     24     2 13   8 17   94     20     0
21     02     12     15     22     12     1
4 14   4 13   4 70   33 79   31 20   83     1
6 94   44 183   118 263   147 383   214 127   57 40   16
8 186   99 299   166 508   342 879   64 172   91 33   16
12 279   105 424   161 1,438   578 2,108   857 212   83 246   82
Vaccinated
0 23   14 10   6 64   48 40   30 31   20 1   1
2a 92   88 36   30 178   197 87   88 87   80 16   13
4b 325   257 226   192 1,355   981 954   743 593   426 187   164
6 294   126 111   61 1,821   855 498   301 508   265 24   14
8 315   121 60   33 2,510   953 291   157 920   350 13   7
12 225   105 64   38 1,890   868 388   196 605   331 25   13
Vaccinated/CD4 c
03     17     42     1
2a 22   12 102   97 21   12
4b 501   141 1,779   86 312   107
6 334   133 1,009   673 248   104
8 206   62 1,015   422 172   53
12 201   119 1,234   758 263   162
Data represent an average of four independent experiments (lungs of 6–12 mice per group were pooled at each time point). Mice were infected with
2   103 yeast and analyzed serially after infection.
aP   0.01 vs. unvaccinated mice for all three cytokines.
bP   0.005 vs. unvaccinated mice for all three cytokines.
cC57BL/6 mice were depleted of CD4  T cells during the induction and expression phase of vaccine immunity. T
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sharply increased lung CFU compared with the rat IgG
control (Fig. 5 B). These results illustrate that CD8  T cells
are flexible in the mechanisms at their disposal for mediat-
ing vaccine immunity in the absence of type 1 cytokines
IFN-  and TNF- .
Discussion
AIDS patients manifest impaired or defective CD4  T
cell responses and are predisposed to opportunistic mi-
crobes, suggesting that CD4  T cells play an essential role
in host resistance (1, 2). Other lines of evidence indicate
that resistance against such microbes including fungi is
largely mediated by protective CD4  T cells (29, 30, 33,
36, 37). Thus, it would seem impossible to vaccinate this
growing population of immune-compromised patients
against opportunistic fungi. To test this premise, we ex-
plored whether in immune-deficient mice lacking CD4  T
cells we could harness residual cellular and molecular ele-
ments in vaccine immunity to fungi.
Herein, we provide evidence that CD4  T cells are dis-
pensable in vaccine immunity against experimental pulmo-
nary blastomycosis and histoplasmosis. CD8  T cells alone,
in the absence of CD4  T cells, could induce and mediate
vaccine resistance against lethal infections with these patho-
genic fungi. We used multiple independent approaches to
support our findings. First, we depleted CD4  T cells in
wild-type mice during vaccination and throughout infec-
tion. Both survival and burden of infection outcomes indi-
cated that CD4  T cells are dispensable for vaccine immu-
nity. Vaccine resistance in CD4-depleted wild-type mice
was durable and persisted at least 8 wk after vaccination.
Second, vaccination of CD4- or class II-knockout mice ge-
netically deficient in CD4  T cells confirmed our findings
in CD4-depleted wild-type mice. Vaccinated CD4 knock-
out mice were as resistant as vaccinated wild-type mice and
survived a lethal infection. Furthermore, vaccinated CD4-
deficient mice mounted a granulomatous inflammatory re-
sponse in lungs that was comparable to that in wild-type
mice. Although granuloma formation is considered a
form of delayed-type hypersensitivity requiring principally
MHC class II–restricted CD4  T cells, other cells and anti-
bodies can replace them. During Mycobacterium tuberculosis
infection, granuloma formation in CD4-deficient mice was
delayed by about one week vs. wild-type mice, but at later
times, the numbers of granulomas in lung and liver sections
were comparable (38). Third, elimination of CD8  T cells
in vaccinated CD4-deficient mice during vaccine expres-
sion largely abolished resistance, indicating that CD8  T
cells are responsible for the resistance. Fourth, resistance by
immune CD8  T cells could be adoptively transferred to
naive mice.
We saw a subtle difference in the amount of lung inflam-
mation of vaccinated CD4-knockout or -depleted mice
versus vaccinated wild-type mice. The former groups had
slightly more lung inflammation, but the lung tissue of
both immune-deficient groups was still largely devoid of
inflammatory cells (93 and 96%, respectively). Pathogenesis
and tissue injury is the net result of microbial growth versus
the host response to pathogen and collateral tissue damage
(39). Though vaccine induces protection in CD4-deficient
hosts, increased inflammatory response could reflect loss of
subsets of T cells important in regulating inflammation.
CD8  T cells have been reported to mediate secondary
immunity or vaccine immunity in the absence of CD4  T
cells; for example, in secondary immunity to H. capsulatum
(30) and vaccine immunity to Leishmania major (40). In
those studies, experimental animals had an intact immune
system upon initial infection or vaccination, and CD8  T
cells were shown to play a prominent role in protection
after rechallenge during the expression phase of immunity.
By contrast, in our study, animals congenitally lacked
CD4 T cells or had them depleted before they were vacci-
nated. Hence, they were immune-deficient hosts lacking
CD4  T cells during the induction phase of vaccine im-
munity (and also during the expression phase). Neverthe-
less, CD8  T cells alone were sufficient both for the in-
duction and expression of immunity, and robust resistance
Figure 5. Plasticity of CD8  T cells in vaccine immunity. (A) Vacci-
nated, CD4-depleted IFN-  /  mice (10/group) received mAb against
TNF- , GM-CSF, CD8  cells, or rat IgG (control [C]) throughout B.
dermatitidis infection. Lung CFU was analyzed 2 wk after infection. Values
depicted are mean CFU   SEM. *, P   0.0006 vs. rat IgG control treated
mice; **, P   0.005 vs. rat IgG control mice. (B) Vaccinated, CD4-
depleted TNF-  /  mice (8–9/group) received anti-IFN- , anti-GM-CSF,
or anti-CD8 mAb throughout infection and were analyzed for lung CFU
2 wk after infection. Data are geometric mean CFU   SEM. *, P   0.0006
vs. rat IgG control mice; **, P   0.004 vs. rat IgG control treated mice.T
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was demonstrable against both extracellular and intracellu-
lar fungal pathogens.
According to dogma, induction of CD8  T cell re-
sponses against exogenously processed antigens requires
CD4  T cell help (41–43). T helper cell–induced stimula-
tion of CD40 on macrophages and dendritic cells (DCs) is a
commonly described mechanism that leads to up-regulation
of costimulatory molecules and induction of cytokines, such
as IL-12, to “condition” an APC to stimulate naive CD8 
T cells. Recent reports provide evidence of some flexibility
for the CD4  T cell requirement. Harty and colleagues (44)
reported that during Listeria monocytogenes infection bacterial
antigens that did not have access to endogenous MHC class
I processing pathways were able to overcome the require-
ment for CD40L in exogenous antigen presentation to
CD8  T cells. Bachmann and colleagues (45) showed that
DC maturation occurred in vivo after infection with
LCMV and vesicular stomatitis virus in the absence of
CD40 and T helper cells. This maturation did not require
viral infection of DCs but was mediated by peptide-specific
CD8  T cells. Wang and colleagues (16) showed that, in
the absence of preactivated APCs or of inflammatory signals
that substitute for help during bacterial and viral infections
(46, 47), CD8  T cells can help for other responding CD8 
T cells, when present in sufficient numbers. Besides CD8 
T cells, possibly other cells (e.g., NK cells) too can substi-
tute for CD4  Th cells under appropriate conditions.
Recently, CD8  effector T cells have been generated by
DNA or protein/CpG oligodeoxynucleotides (ODN) vac-
cines in a CD4- and CD40L-independent manner. For ex-
ample, an immunostimulatory DNA-based vaccine in-
duced CTL to the model antigen OVA through a T
helper–independent mechanism (48). Vaccine-induced
CTLs were also able to suppress in vivo growth of the
E.G7 cell line transfected with OVA. This study offered
early evidence that, in the absence of T cell help, cross
priming of CD8 cells by an ODN vaccine induces CTL
that lyse “tumor” targets and suppress their growth when
they express the model antigen OVA.
The authors above speculated on whether ODN-based
vaccines and cross priming might allow vaccination of im-
mune-deficient hosts. Here, we provide unequivocal ex-
perimental evidence of T helper–independent vaccination
of immune-deficient hosts against infectious diseases, and
prove this principle in two separate models of systemic fun-
gal diseases that can commonly afflict AIDS patients. The
profile of CD8 immunity raised in our study differed from
that where ODN was used. Cho et al. (48) failed to detect
type 1 cytokine and Horner et al. (49) detected weak re-
sponses using ODN vaccines without T cell help. In our
study, CD4-independent, CD8  T cells generated IFN- ,
TNF- , and GM-CSF, which were linked with and essen-
tial in vaccine resistance. Maintenance of type 1-cytokine
responses may be crucial for control of fungal and other eu-
karyotic intracellular infections, but dispensable in CTL
control of tumor or viral processes.
An enigma is how CD8  T cells become activated dur-
ing infections with B. dermatitidis, a predominantly extra-
cellular pathogen, and with H. capsulatum, an intracellular
pathogen that resides in the phagolysosome with no dem-
onstrated access to the cytosol. To elucidate how CD8  T
cells are activated, we explored the requirements for MHC
class I. An unconventional mechanism of CD8  T cell im-
munity to C. albicans and C. neoformans has been proposed
involving direct binding of T cells to the fungi in the ab-
sence of MHC and accessory cells. Direct in vitro antimi-
crobial activity of T cells has been described with C. albi-
cans and C. neoformans (24), and against parasites Toxoplasma
gondii (50), Schistosoma mansoni (51), and Entamoeba histolyt-
ica. While the above examples show that T cells can di-
rectly inhibit or kill various pathogens in vitro, the circum-
stances by which direct T cell–mediated antimicrobial
activity contributes to host defenses in vivo remain unclear.
In our study, adoptively transferred CD8  T cells protected
wild-type mice, but not class I–deficient mice, suggesting
that CD8  T cell immunity against B. dermatitidis requires
MHC class I for antigen presentation and protection.
Although cross-presentation of exogenous antigens to
MHC class I molecules is observed in various infections,
the route of uptake and processing, and the compartment
where peptides combine with MHC class I may differ. Our
recent experiments have shown that protective CD8  T
cells recognize exogenous fungal antigens largely in a TAP-
independent manner (unpublished observations), suggest-
ing a nonclassical pathway for antigen presentation. It will
be important to investigate the pathway(s) used for cross-
presentation of B. dermatitidis and H. capsulatum antigens on
MHC class I. Their understanding is relevant for the devel-
opment of vaccines meant to induce protective CD8  T
cell immunity to benefit immune-compromised patients.
Vaccine resistance mediated by CD8  T cells required
the production of type 1 cytokines. Independent and com-
bined neutralization of TNF- , IFN- , and GM-CSF dur-
ing the expression phase of CD8  T cell immunity greatly
impaired resistance. TNF-  neutralization reduced vaccine
immunity 5-fold or 30-fold more than IFN-  or GM-CSF
neutralization, respectively, indicating the hierarchical con-
tribution of these cytokines. On analysis by real time PCR
and intracellular staining, lung CD8  T cells demonstrated
significantly enhanced expression of these type 1 cytokines
between 2 to 4 d after infection in vaccinated mice com-
pared with unvaccinated mice. This rapid increase of cyto-
kine expression by CD8  T cells in CD4-depleted mice
(and by both CD4  and CD8  T cells in vaccinated wild-
type mice) early after infection coincided with a sharp re-
duction in lung CFU. Although CD8  T cells are one im-
portant source of these products, we cannot exclude other
cellular sources. Even though quantification of cytokine
producing T cells in lung revealed significant differences
between vaccinated and unvaccinated mice, more refined
analysis of the lung microenvironment by laser capture mi-
cro-dissection could magnify these differences or demon-
strate other cells and products that contribute to vaccine
immunity (52, 53).
As IFN-  and TNF-  were key regulators of CD8  T
cell–mediated resistance, it was surprising that robust vac-T
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cine immunity could be induced and expressed in both
IFN-  /  and TNF-  /  mice. Either reciprocal cytokine
or alternatively GM-CSF could compensate, illustrating
that CD8  cells show plasticity similar to CD4  cells in
their capacity to regulate vaccine immunity (33). Hence,
IFN-  and TNF-  are independently regulated and dis-
pensable in vaccine immunity to B. dermatitidis infection in
a CD4  T cell–deficient host.
In conclusion, we offer firm evidence, in two indepen-
dent experimental animal model systems, that fungal vac-
cines can protect hosts that are immune-compromised at
both the cellular and molecular level. Vaccinated animals
acquired potent and durable cellular immunity in the ab-
sence of CD4  cells and cytokines critically important for
resistance in a normal host. Immune-deficient hosts relied
on alternative mechanisms for vaccine immunity. Our
findings provide encouragement that vaccines can be de-
signed that will protect even immune-deficient hosts.
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